Juno et al. studied CD26 expression levels on γδ T cells of patients with end-stage renal disease (ESRD) and found a significant reduction of CD26 expressing γδ T cells compared to healthy controls. The gene discussed is DPP4; the disease is stage 5 chronic kidney disease.